-
Join 2,525 other subscribers
-
Recent Posts
DCIS 411
Follow @dcis411 on Twitter
My TweetsTop Posts & Pages
- Why DCIS 411?
- NO Informed Consent -- Harmed by 5 Titanium Clips in Breast -- DCIS Patient Shares Her Story and Advocacy
- Over-diagnosis 411
- Holistic Health
- Donna's Journey
- 31 Days of “Little Known” FACTS — For Breast Cancer Awareness Month — Day 12 — Switzerland Review Board Recommended Abolishing Mammography Screening
- FAQ
- Donna’s Super Green-berry Protein Organic Smoothie
- 31 Days of “Little Known” FACTS — For Breast Cancer Awareness Month — Day 31 -- Trick or Truth?
- Listen to My Phone Consultation with Dr. Michael Lagios
-
Recent Posts
- Stage 0 DCIS Saga — Guest Blog by Lynn Good January 25, 2023
- No Surgery for DCIS — Studies and Support January 16, 2023
- Great News about SonoCine Automated Breast Ultrasound — A Message from Dr. Kevin Kelly January 4, 2023
- DCIS is NOT Breast Cancer — An Online Support Group Leading a Paradigm Shift September 14, 2022
- The Case for NO TREATMENT of Low-risk DCIS July 22, 2022
Archives
- January 2023
- September 2022
- July 2022
- June 2022
- March 2022
- January 2022
- April 2021
- October 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- November 2019
- October 2019
- September 2019
- July 2019
- June 2019
- January 2019
- November 2018
- August 2018
- June 2018
- April 2018
- January 2018
- April 2017
- March 2017
- January 2017
- December 2016
- October 2016
- September 2016
- May 2016
- April 2016
- November 2015
- October 2015
- August 2015
- July 2015
- May 2015
- April 2015
- February 2015
- January 2015
- December 2014
- October 2014
- May 2014
- February 2014
- December 2013
- November 2013
- October 2013
- June 2013
- May 2013
- April 2013
- March 2013
- January 2013
- December 2012
- November 2012
- October 2012
- July 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
Support
Tag Archives: Oncotype DX
BS stands for Blue Shield
Dr. Esserman ordered the Oncotype DX Test for me over 1 month ago (see post “What is Oncotype DX?”) Today I received Blue Shield’s denial letter stating: “A physician advisor has reviewed the information provided and determined that the requested service … Continue reading →
Posted in Options, Personal Stories, Resources
|
Tagged breast cancer treatment, denial letter, gene expression profiling, Oncotype DX
|
4 Comments
What Is Oncotype DX?
Oncotype DX is the first clinically validated commercial genomic assay for patients with DCIS. Oncotype DX reveals the underlying biology that can help guide DCIS treatment decisions by predicting the risk of any local recurrence of breast cancer (DCIS or … Continue reading →
DCIS 411 